Inter-subject variability in intestinal drug solubility

International Journal of Pharmaceutics
Sarit Cohen RabbieAbdul W Basit

Abstract

Variability in oral drug absorption is a well-known phenomenon, but it is often overlooked for its potential effects in oral drug delivery. Understanding the mechanisms behind absorption variability is crucial to understanding and predicting drug pharmacokinetics. In this study, the solubility of furosemide and dipyridamole - drugs known to have highly variable oral bioavailabilities - was investigated in individual ileostomy fluids from 10 subjects with ulcerative colitis. For comparison, drug solubility was also determined in pooled upper gastrointestinal fluids from healthy human subjects and simulated intestinal fluids. Ileostomy fluid characterization revealed high variability in buffer capacity and to a lesser degree for pH. Drug solubility in ileostomy fluids showed high variability. Correlation analysis revealed that dipyridamole solubility in these fluids is pH-dependent, whereas furosemide solubility was highly correlated to buffer capacity and pH. The implications of these results might partly explain the high variability in bioavailability in vivo, assuming that most of the observed variability is due to the absorption, and not the elimination, process.

References

Apr 1, 1977·British Journal of Clinical Pharmacology·S M RajahD A Watson
Jun 1, 1981·Journal of Medicinal Chemistry·G D DianaB A Steinberg
Jan 1, 1984·European Journal of Clinical Pharmacology·A GrahnénT Lundqvist
Jan 1, 1983·Thrombosis Research. Supplement·T D Bjornsson, C Mahony
Jan 1, 1984·European Journal of Clinical Pharmacology·M M HammarlundB Odlind
Oct 1, 1982·Journal of Pharmaceutical Sciences·E S WallerJ T Doluisio
Jul 24, 2007·Advanced Drug Delivery Reviews·Alex Avdeef
Jul 8, 2008·International Journal of Pharmaceutics·Emma L McConnellAbdul W Basit
Mar 10, 2009·Pharmaceutical Research·Sarah ClaryssePatrick Augustijns
Oct 20, 2009·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·Pieter AnnaertPatrick Augustijns
Dec 5, 2009·Journal of Pharmaceutical Sciences·G E GraneroD M Barends
Aug 12, 2010·Molecular Pharmaceutics·Erik SöderlindJennifer J Sheng
May 17, 2011·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·Sarah ClaryssePatrick Augustijns
Jun 7, 2011·International Journal of Pharmaceutics·Ana C FreireHamid A Merchant
Apr 25, 2013·International Journal of Pharmaceutics·F J O VarumA W Basit

❮ Previous
Next ❯

Citations

Feb 18, 2016·Journal of Pharmaceutical Sciences·Masashi MizoguchiTakashi Inui
Dec 7, 2018·Biological & Pharmaceutical Bulletin·Shunsuke KimuraToshiyasu Sakane
Jul 11, 2020·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·Angela EffingerNikoletta Fotaki
Mar 29, 2021·Advanced Drug Delivery Reviews·Souhaila H El MoukhtariMaría J Blanco-Prieto

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

The Australian and New Zealand Journal of Surgery
E S HUGHESA B CARDEN
The British Journal of Clinical Practice
G SLANEY
The Medical Journal of Australia
E E DUNLOP
© 2022 Meta ULC. All rights reserved